@ Newsroom | SEBIO

Richmond SCORE announces 2017 entrepreneurship competition

Posted by on Dec 6, 2016 in Newsroom | 0 comments

RICHMOND, VA. – Richmond SCORE, in partnership with the Virginia Biotechnology Research Park, will launch its second Business Model Canvas Competition Jan. 1. The nonprofit volunteer mentoring organization is inviting all Richmond-area entrepreneurs and start-ups (new businesses up to one year old and that haven’t won money or tangibles in a business competition in the same time frame) to apply as contestants. Nonprofits also are encouraged to apply. “Participants’ presentations will be evaluated by a distinguished panel of Richmond business community leaders” said Art...

Read More

12 ‘One NC’ startup grant recipients also have Biotech Center backing

Posted by on Nov 28, 2016 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – Twenty-nine small companies – most of them in the biosciences – received grants totaling $1.7 million from the One North Carolina Small Business Program in the latest quarter ending Oct. 30. Of those, 12 also have landed backing from the North Carolina Biotechnology Center. The companies, located in 13 communities across the state, will use the money to develop new products, hire employees and buy equipment and materials. The program provides state grants to match federal funds awarded through the highly competitive Small Business Innovation Research...

Read More

Wilmington startup Optima aiming to energize hog waste

Posted by on Nov 28, 2016 in Newsroom | 0 comments

WILMINGTON, N.C. – Power to the people through pig poop. That’s the business mission of a new Wilmington company, Optima BioEnergy, that is aiming to capture renewable natural gas from swine manure that would otherwise decay and pollute the atmosphere with greenhouse gases. The company’s first project, undertaken by its limited liability company Optima KV, will generate natural gas from 60,000 hogs at three farms in nearby Duplin County, the heart of North Carolina’s 9-million-hog pork industry. The gas will be sold to Duke Energy to generate electricity. “Optima is excited...

Read More

HudsonAlpha acts as catalyst for Alabama bioscience growth

Posted by on Nov 23, 2016 in Newsroom | 0 comments

HUNTSVILLE, AL. – From world-class researchers to worried parents, people across all walks of life are finding answers at HudsonAlpha Institute for Biotechnology. Set on 152 acres in Huntsville’s Cummings Research Park, the nonprofit institute is a pillar of Alabama’s biotech industry and, beyond that, a global leader in genetics and genomic technology. HudsonAlpha brings scientists, entrepreneurs and educators together to collaborate at one site. The campus includes more than 30 bioscience companies, is responsible for almost 1,200 direct and indirect jobs and has an estimated...

Read More

TARGET PharmaSolutions Partners with Bristol-Myers Squibb, Offering a New Platform to Collect Real World Data

Posted by on Nov 11, 2016 in Newsroom | 0 comments

CHAPEL HILL, N.C. – TARGET PharmaSolutions, Inc., a clinical data company focused on real world evidence, is pleased to announce two new collaborations with Bristol-Myers Squibb (BMY) to advance the understanding of treatment patterns in nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). The TARGET model provides pharmaceutical and biotechnology partners access to a robust disease state registry that is also linked to a biorepository and patient reported outcomes, providing unique data and insights compared to typical patient registries. “The unique collaboration...

Read More

Vivo Biosciences acquired by Virginia company

Posted by on Nov 4, 2016 in Newsroom | 0 comments

VIRGINIA BEACH, VA. and BIRMINGHAM, AL. – Birmingham biotech company Vivo Biosciences has been acquired by Virginia-based LifeNet Health. The organ transplant solutions company announced the acquisition Wednesday, saying Vivo’s unique technology will add to LifeNet’s growing emphasis on personalized medicine. Founded in 2004 by cancer researcher Raj Singh, Vivo Biosciences created and patented its HuBiogel technology, which Singh likens to a glue used for holding cells together. The cells bounded by HuBiogel are developed into tumor models, which Vivo then uses to test...

Read More